Keywords
antifungal agents
immunosuppression
MALDI-TOF-MS
Aspergillus
Categories
How to Cite
Abstract
Summary:
A corneal abscess is defined by the occurrence of a corneal infiltrate in relation to an epithelial ulceration of infectious origin. We report a case of corneal abscess due to Aspergillus flavus in a teenage girl without any notion of immunodepression or ocular trauma. The culture for a search of a bacterial origin is negative, whereas the diagnosis of a fungal origin is suspected due to a fluffy colonies. The diagnosis was confirmed by a Maldi-tof mass spectrometry. The treatment was fluconazole and amphotericin eye drop associated with vancomycin. The complications to be feared for this patient are blindness, ocular perforation or even passage to the other eye.
References
Green M, Apel A, Stapleton F. Risk Factors and Causative Organisms in Microbial Keratitis. Cornea. 2008;27(1):22-27. doi:10.1097/ICO.0b013e318156caf2
Brown L, Leck AK, Gichangi M, et al. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis. 2021;21(3):e49-e57. doi:10.1016/S1473-3099(20)30448-5
Said DG, Elalfy MS, Gatzioufas Z, et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 2014;121(7):1377-1382. doi:10.1016/j.ophtha.2014.01.011
Ghosh AK, Gupta A, Rudramurthy SM, Paul S, Hallur VK, Chakrabarti A. Fungal keratitis in North India: spectrum of agents, risk factors and treatment. Mycopathologia. 2016;181(11-12):843-850. doi:10.1007/s11046-016-0044-2
Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep. 2013;7(3):209-218. doi:10.1007/s12281-013-0150-1
Gower EW, Keay LJ, Oechsler RA, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010;117(12):2263-2267. doi:10.1016/j.ophtha.2010.03.048
Gaujoux T, Borsali E, Goldschmidt P, et al. Fungal keratitis in France. Acta Ophthalmol. 2011;89(4):e215-e216. doi:10.1111/j.1755-3768.2010.02046.x
Nielsen SE, Nielsen E, Julian HO, et al. Incidence and clinical characteristics of fungal keratitis in a Danish population from 2000 to 2013. Acta Ophthalmol. 2015;93(1):54-58. doi:10.1111/aos.12440
Ho JW, Fernandez MM, Rebong RA, Carlson AN, Kim T, Afshari NA. Microbiological profiles of fungal keratitis: a 10-year study at a tertiary referral center. J Ophthalmic Inflamm Infect. 2016;6(1):5. doi:10.1186/s12348-016-0071-2
Tanure MAG, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR. Spectrum of Fungal Keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19(3):307-312. doi:10.1097/00003226-200005000-00010
Normand AC, Cassagne C, Ranque S, et al. Assessment of various parameters to improve MALDI-TOF MS reference spectra libraries constructed for the routine identification of filamentous fungi. BMC Microbiol. 2013;13:76. doi:10.1186/1471-2180-13-76
Shah A, Sachdev A, Coggon D, Hossain P. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br J Ophthalmol. 2011;95(6):762-767. doi:10.1136/bjo.2009.169607 (Pages et syntaxe complétées)
Bourcier T, Sauer A, Dory A, Denis J, Sabou M. Kératites fongiques. J Fr Ophtalmol. 2017;40(10):882-888. doi:10.1016/j.jfo.2017.05.013
Kadiri M, Tlamçani Z. Performances de la Spectrométrie De Masse MALDI-TOF dans l’identification parasitaire et fongique. IOSR J Pharm Biol Sci. 2024;19(3):36-43. doi:10.9790/3008-1903033643 (Année corrigée selon l'index de la revue)
Anane S, Ben Ayed N, Malek I, et al. Les kératites fongiques dans la région de Tunis: caractéristiques épidémiologiques, modalités diagnostiques et thérapeutiques. Ann Biol Clin (Paris). 2010;68(4):441-447. doi:10.1684/abc.2010.0452
Mahmoudi S, Masoomi A, Ahmadikia K, et al. Fungal keratitis: An overview of clinical and laboratory aspects. Mycoses. 2018;61(12):916-930. doi:10.1111/myc.12822
Société Française d’Ophtalmologie (SFO). Les kératites fongiques : aspects épidémiologiques, cliniques et thérapeutiques (à propos de 28 cas). SFO-online. Mis en ligne en mai 2017. Consulté le 23 janvier 2026. Disponible sur: https://www.sfo-online.fr/
Karthikeyan RS, Leal SM Jr, Prajna NV, et al. Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or Fusarium. J Infect Dis. 2011;204(6):942-950. doi:10.1093/infdis/jir389
Mukherjee PK, Chandra J, Yu C, et al. Characterization of Fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis. Invest Ophthalmol Vis Sci. 2012;53(8):4450-4457. doi:10.1167/iovs.11-8946
Donovan C, Arenas E, Ayyala RS, et al. Fungal keratitis: mechanisms of infection and management strategies. Surv Ophthalmol. 2022;67(3):758-769. doi:10.1016/j.survophthal.2021.08.002
Prajna NV, Krishnan T, Mascarenhas J, et al. The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422-429. doi:10.1001/jamaophthalmol.2013.1497
Prajna NV, Prajna L, Muthiah S. Fungal keratitis: the Aravind experience. Indian J Ophthalmol. 2017;65(10):912-919. doi:10.4103/ijo.IJO_842_17
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Razafindranaivo TT, Randriambola HV, Zafindraibe NJ, Tsatoromila AM, Ralambohenintsoa ZN, Rasamoelina TM, Razanakolona LRS